Hemato-Oncology-35-Non Hodgkin’s Lymphoma-treatment broadly
HEMATO-ONCOLOGY PART-35 Question: Dr. Chiragbhai, thank you for explaining in last part about Non Hodgkin’s Lymphoma importance of IHC in diagnosis and treatment, staging, and prognostic tools. We learnt a very important lesson that diagnosis of lymphoma is not sufficient, subtyping is important, for prognosis and some important treatment decisions. Now, can you tell us […]
More